Efficacy and Safety Evaluation According to Plasma Concentration Measurement on Direct Oral Anticoagulation Using Factor-Xa Inhibitors for Non-valvular Atrial Fibrillation on Multicenter Study
Not Applicable
Recruiting
- Conditions
- on-valvular atrial fibrillation
- Registration Number
- JPRN-UMIN000036769
- Lead Sponsor
- Hokusetsu General Hospital Clinical laboratory division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients judged by the attending physician as inappropriate for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding and thrombosis events and blood DOAC concentration from the start of medication to 12 months
- Secondary Outcome Measures
Name Time Method Measurement values of molecular markers and coagulation tests from the start of medication to 12 months